Vice President, Medical Affairs
@ Lexeo TherapeuticsVice President, Medical Affairs
This job is still taking applications, but it's been up a while.
About the job
Lexeo Therapeutics is a genetic medicine company focused on cardiac genetic therapies. The VP leads Medical Affairs, shaping strategy, scientific communication, and stakeholder engagement.
Requirements
- 10+ years industry experience
- Medical Affairs leadership
- Scientific communication expertise
- Experience scaling capabilities
- Strong communication skills
Qualifications
- Advanced degree in life sciences or medicine
- MD, PharmD, PhD preferred
- Experience in biotech or pharma
- Ability to operate strategically and hands-on
- Experience with real-world data
Full job description
Role Summary
The Vice President, Medical Affairs will provide enterprise-level leadership across Lexeo’s gene therapy program. Reporting to the Chief Medical Officer, this role will set the strategic direction for Medical Affairs, overseeing scientific communications, congress strategy, external expert engagement, medical information, medical evidence generation and medical education. This individual will serve as a senior cross-functional leader and strategic partner to Clinical Development, Regulatory, and Patient Advocacy teams.
In this role, they will shape and scale the Medical Affairs function, build organizational capabilities, and drive external scientific leadership in support of Lexeo’s development and future commercialization objectives. The ideal candidate is a strategic, hands-on leader who thrives in a dynamic, high-growth environment and can influence across the organization and external stakeholders.
Primary Responsibilities
Required Skills and Qualifications
About Lexeo
Lexeo Therapeutics is a clinical-stage genetic medicine company headquartered in New York City, pioneering cardiac genetic medicine candidates to treat the root causes of inherited cardiovascular diseases. Our lead program, LX2006, targets cardiomyopathy associated with Friedreich’s Ataxia and anchors a broader pipeline addressing genetically defined conditions such as hypertrophic and arrhythmogenic cardiomyopathies. Backed by a strong financial foundation, Lexeo is positioned to translate groundbreaking science into durable clinical impact.
Our work culture is a hybrid model with 2 days/week in the New York City office and 3 days working from home.
Lexeo Therapeutics is an EEO employer committed to an exciting, diverse, and enriching work environment.